K Prabhakar
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Natural Antidiabetic Agents Studies, Phytochemistry and Biological Activities, Tuberculosis Research and Epidemiology, Essential Oils and Antimicrobial Activity
Most-Cited Works
- → U.S. FDA Approved Drugs from 2015–June 2020: A Perspective(2021)714 cited
- → Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition(2016)167 cited
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → Ficus racemosa Stem Bark Extract: A Potent Antioxidant and a Probable Natural Radioprotector(2007)104 cited
- → Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: A mechanistic study(2011)102 cited
- → Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents(2014)89 cited
- → Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice(2006)87 cited
- → Antibacterial activity of some salt marsh halophytes and mangrove plants against methicillin resistant Staphylococcus aureus(2008)74 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → Identification and evaluation of antioxidant, analgesic/anti-inflammatory activity of the most active ninhydrin–phenol adducts synthesized(2006)72 cited